Cancer vaccines.
Journal Article (Journal Article)
Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.
Full Text
Duke Authors
Cited Authors
- Schiller, JT; Lowy, DR; Frazer, IH; Finn, OJ; Vilar, E; Lyerly, HK; Gnjatic, S; Zaidi, N; Ott, PA; Balachandran, VP; Dietrich, P-Y; Migliorini, D; Vonderheide, RH; Domchek, SM
Published Date
- June 13, 2022
Published In
Volume / Issue
- 40 / 6
Start / End Page
- 559 - 564
PubMed ID
- 35700704
Pubmed Central ID
- PMC9190070
Electronic International Standard Serial Number (EISSN)
- 1878-3686
Digital Object Identifier (DOI)
- 10.1016/j.ccell.2022.05.015
Language
- eng
Conference Location
- United States